Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,289.60
(
0.00%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.57
(
-1.13%
)
Bitcoin
80,930.53
(
0.55%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Protector

Send PM Follow Ignore
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Protector

Re: cheynew post# 267205

Thursday, 06/23/2016 10:26:01 AM

Thursday, June 23, 2016 10:26:01 AM

Post# of 347009
cheynew, if you ask such question you might want to be more specific. A Total Buy-out, an Oncology Buy-out and Avid Buy-Out, only Bavituximab or with BetaBodies, patents, pipelines...

Actually the master in these kind of things was RRDog and there was another poster that also made quite good estimates.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote